Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page
- Check3 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help/navigation sections were added to guide users on reading the study record and joining the study. The header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag was updated to v3.6.0.SummaryDifference0.3%

- Check10 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, reflecting a small metadata update to the study record.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.5.4 appears on the page, replacing the previous v3.5.3. This reflects an internal update to the page version without altering the study details or visible content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s displayed software/interface revision number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check60 days agoChange DetectedThe site revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page now shows an updated Revision tag: v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.